The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7813-7820

  Chalasani, Geetha ^a   Li, Qi ^a   Konieczny, Bogumila T ^b   Smith Diggs, Lonnette ^a   Wrobel, Barbara ^c   Dai, Zhenhua ^a   Perkins, David L ^d   Baddoura, Fady K ^c   Lakkis, Fadi G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; COLLAGEN TYPE 5; LAMININ; PROCOLLAGEN; SCLEROPROTEIN; TENASCIN;

ACUTE GRAFT REJECTION; ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNE RESPONSE; ISCHEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; T LYMPHOCYTE;

EID: 2942530583     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7813     Document Type: Article

References (39)

1. Libby, P., and J. S. Pober. 2001. Chronic rejection. Immunity 14:387.
2. Vella, P., M. Spadafora-Ferreira, B. Murphy, S. I. Alexander, W. Harmon, C. B. Carpenter, and M. H. Sayegh. 1997. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 64:795.
3. Ciubotariu, R., Z. Liu, A. I. Colovai, E. Ho, S. Itescu, S. Ravalli, M. A. Hardy, R. Cortesini, E. A. Rose, and N. Suciu-Foca. 1998. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J. Clin. Invest. 101:398.
4. Baker, R. J., M. P. Hernandez-Fuentes, P. A. Brookes, A. N. Chaudhry, H. T. Cook, and R. I. Lechler. 2001. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J. Immunol. 167:7199.
5. Najafian, N., A. Salama, E. Fedoseyeva, G. Benichou, and M. Sayegh. 2002. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J. Am. Soc. Nephrol. 13:252.
6. Womer, K. L., J. R. Stone, B. Murphy, A. Chandraker, and M. H. Sayegh. 2001. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. J. Am. Soc. Nephrol. 12:2500.
7. Lee, R. S., K. Yamada, S. L. Houser, K. L. Womer, M. E. Maloney, H. S. Rose, M. H. Sayegh, and J. C. Madsen. 2001. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc. Natl. Acad. Sci. USA 98:3276.
8. Valujskikh, A., D. Matesic, A. Gilliam, D. Anthony, T. M. Haqqi, and P. S. Heeger. 1998. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J. Clin. Invest. 101:1398.
9. He, C., S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger. 2004. Effects of T cell frequency and graft size on transplant outcome in mice. J. Immunol. 172:240.
10. Lechler, R. I., and J. R. Batchelor. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155:31.
11. Krasinkas, A. M., S. D. Eiref, A. McLean, D. Kreisel, A. E. Gelman, S. H. Popma, S. Jonni, and B. R. Rosengard. 2000. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection. Transplantation 70:514.
12. Koene, R. 1989. The role of adaptation in allograft acceptance. Kidney Int. 35:1073.
13. Woodruff, M., and H. Woodruff. 1950. The transplantation of normal tissues: with special reference to auto- and homotransplants of thyroid and spleen in the anterior chamber of the eye, and subcutaneously, in guinea-pigs. Philos. Trans. R. Soc. London (Biol.) 234:559.
14. Nirmul, G., C. Severin, and R. Taub. 1972. Adaptation of skin allografts in mice treated with antilymphocyte serum. Transplantation 13:27.
15. McKenzie, I., R. Koene, and H. Winn. 1972. Evidence for adaptation of skin grafts in enhanced, irradiated mice. Transplantation 14:661.
16. Gianello, P., K. Yamada, J. Fishbein, T. Lorf, V. Nickeleit, R. Colvin, J. Arn, and D. Sachs. 1996. Long-term acceptance of primarily vascularized renal allografts in miniature swine: systemic tolerance versus graft adaptation. Transplantation 61:503.
17. Onodera, K., H. Volk, T. Ritter, and J. Kupiec-Weglinski. 1998. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J. Immunol. 160:5765.
18. Corry, R. J., H. J. Winn, and P. S. Russel. 1973. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non H-2 antigens. Transplantation 16:343.
19. Konieczny, B. T., Z. Dai, E. T. Elwood, S. Saleem, P. Linsley, F. K. Baddoura, C. P. Larsen, T. C. Pearson, and F. G. Lakkis. 1998. IFNγ is critical for long term allograft survival induced by blocking the CD28 and CD40L T cell costimulation pathways. J. Immunol. 160:2059.
20. Chalasani, G., Z. Dai, B. T. Konieczny, F. K. Baddoura, and F. G. Lakkis. 2002. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 99:6175.
21. Christopher, K., T. Mueller, C. Ma, Y. Liang, and D. Perkins. 2002. Analysis of innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J. Immunol. 169:522.
22. Akalin, E., R. C. Hendrix, R. G. Polavarapu, T. C. Pearson, J. F. Neylan, C. P. Larsen, and F. G. Lakkis. 2001. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 72:948.
23. Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara, and Y. Shibata. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:429.
24. Lakkis, F. G., A. Arakelov, B. T. Konieczny, and Y. Inoue. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686.
25. Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nat. Genet. 22:74.
26. Fagarasan, S., R. Shinkura, T. Kamata, F. Nogaki, K. Ikuta, K. Tashiro, and T. Honjo. 2000. Alymphoplasia (aly)-type nuclear factor κB-inducing kinase causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J. Exp. Med. 191:1477.
27. Karrer, U., A. Althage, B. Odermatt, H. Hengartner, and R. M. Zinkemagel. 2000. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect. Eur. J. Immunol. 30:2799.
28. + T cells. J. Immunol. 164:265.
29. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J. Immunol. 169:4667.
30. Valujskikh, A., B. Pantenburg, and P. Heeger. 2002. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am. J. Transplant. 2:501.
31. Bingaman, A. W., J. Ha, S.-Y. Waitze, M. M. Durham, H. R. Cho, C. Tucker-Burden, R. Hendrix, S. R. Cowan, T. C. Pearson, and C. P. Larsen. 2000. Vigorous allograft rejection in the absence of danger. J. Immunol. 164:3065.
32. Morita, K., M. Miura, D. Paolone, T. Engeman, A. Kapoor, D. Remick, and R. Fairchild. 2001. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J. Immunol. 167:2979.
33. 1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20:167.
34. Riederer, I., S. D. Silva-Barbosa, M. L. Rodrigues, and W. Savino. 2002. Local antilaminin antibody treatment alters the rejection pattern of murine cardiac allografts: correlation between cellular infiltration and extracellular matrix. Transplantation 74:1515.
35. Soares, M., S. Brouard, R. Smith, and F. Bach. 2001. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol. Rev. 184:275.
36. Daemen, M. A. R. C., B. De Vries, and W. A. Buurman. 2002. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73:1693.
37. Coito, A., and J. Kupiec-Weglinski. 2000. Extracellular matrix proteins in organ transplantation. Transplantation 69:2465.
38. Surh, C. D., and J. Sprent. 2000. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J. Exp. Med. 192:F9.
39. Dai, Z., and F. G. Lakkis. 2001. Cutting Edge: Secondary lymphoid organs are necessary for maintaining the CD4, but not CDS, naive T cell pool. J. Immunol. 167:6711.